Fierce Pharma Engage 2025

Discover the remarkable journey of Arcturus Therapeutics, a trailblazing biotech that defied the odds to launch its first approved product—a COVID-19 vaccine—in Japan. This inspiring case study will showcase how a company that started with just $15,000 built a commercialized product through relentless effort, innovative collaboration, and strategic branding. Learn how Arcturus partnered with two prominent drug makers and leveraged an established brand identity to gain trust and recognition in the Japanese market, achieving what many thought impossible for an independent biotech.